Alkermes
ALKS • NASDAQ
Alkermes is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Richard F. Pops, with a market cap of $5.8B.
Market Cap$5.8B
Employees2.1K
CEORichard F. Pops
CountryIreland
Healthcare
Biotechnology
Next EarningsApr 30, 2026 · In 2 weeksQ1 2026
Financials
Alkermes FAQ
Common questions about Alkermes
Alkermes is scheduled to report earnings for Q1 2026 on April 30, 2026. Analysts estimate revenue of $360.9M.
Alkermes has approximately 2,100 employees.